Introduction: The patients with type 2 diabetes (T2D) suffer from the malfunctions of the sexual behaviors, and several mechanisms have been proposed to describe these disorders. The innate immunity may be involved in the malfunctions of T2D patients. Melanoma differentiationassociated protein 5 (MDA5) and retinoic acid (RA)-inducible gene 1 (RIG-1), as the innate immunity receptors, are the responsible molecules for the activation of some intracellular signaling pathways and the induction of inflammation. Thus, this study aimed to examine the molecules which may participate in the induction/stimulation of sexual malfunctions in the female T2D patients. Methods: Sexual functions were evaluated in 41 female T2D patients using the Female Sexual Function Index (FSFI) questionnaire. Real-time polymerase chain reaction (PCR) technique was used to quantify MDA5 and RIG-1 mRNA levels. Results: Results showed that increased RIG-1 mRNA levels were significantly associated with the bad orgasm in the female T2D patients compared to the female patients with good orgasm. Expression of RIG-1 and MDA5 levels were not associated with other sexual functions' criteria.
Introduction
Sexual malfunctions are prevalent disorders in the humans, especially among the patients with immune related diseases. 1 Accordingly, several studies have shown type 2 diabetic patients are main groups who are at risk of sexual malfunctions, especially female patients. 1 Some investigations have approved the negative relations between sexual functions and inflammation. For instance, one study showed that a good sexual maturation suppresses the lung inflammation via the up-regulation of estrogen. 2 Another study showed that sexual function's quality is dependent on the ovarian cycle related to inflammation. 3 Thus, it seems that inflammation has a potential link with sexual functions, but specific molecules involved in inflammation affecting sexual functions are yet to be defined. Innate immunity, as the keystone of the immune system, is activated via the interaction among its sensors, pattern recognition receptors (PRRs), and pathogens-associated molecular patterns (PAMPs)/ damage-associated molecular patterns (DAMPs). [4] [5] [6] The PRRs are expressed either 
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on the cytoplasmic membrane or in the cytoplasm. Melanoma differentiation-associated protein 5 (MDA5) and retinoic acid(RA)-inducible gene 1 (RIG-1) are 2 key cytoplasmic receptors which play key roles in recognition of the viral mRNA and induction of the inflammation in the immune/non-immune cells via the PAMPs and DAMPs recognition and activation of 2 important transcription factors, interferon regulatory transcription factor 3 (IRF3) and nuclear factor-kappa B (NF-kB). 7 Based on the potential correlation between inflammation and type 2 diabetes (T2D) 6, 8, 9 together with high prevalence of sexual malfunctions in the patients, authors of this study hypothesized that alteration in MDA5 and RIG-1 expressions may be associated with sexual malfunctions in the female T2D patients. Thus, this study aimed to assess the possible association between the MDA5 and RIG-1expression levels and sexual malfunctions in the female T2D patients.
Methods

Patients
In this cross-sectional study, T2D patients were diagnosed based on the American Diabetes Association Management Guidelines 10 by an internal medicine doctor (MD). Accordingly, 41 female T2D patients, aged 54.09 ± 2.71 years old, were selected from Kerman Diabetic Clinical Center, Kerman University of Medical Sciences. Females suffering from T2D were included in the study. Blood samples were collected from them and the questionnaires were completed by them. The exclusion criteria were as follows: history of psychiatric disorders, existence of allergy, infectious diseases, cancers, autoimmune diseases, breastfeeding, pregnancy, and immunodeficiencies. Table  1 illustrates the demographic data of the participants. The patients' peripheral blood samples were collected in the tubes consisting anti-coagulant (ethylenediaminetetraacetic acid) for mRNA purification. The patients filled out the written informed consent forms as well as the Female Sexual Function Index (FSFI) questionnaires following the explanation of protocol and aims. Based on the questionnaires, the patients were divided into 2 bad and good sexual function groups. In addition, they were subdivided into other groups in terms of desire, orgasm, satisfaction, pain, arousal, and use of lubricant. The diagnosis of sex malfunctions was made by the psychiatrist. Accordingly, the experimental works including sampling, filling out the questionnaire, and gene analysis were performed in Kerman city.
Real-Time polymerase Chain Reaction RNA was purified from the whole peripheral blood immune cells using a commercial solution RNX (Catalog number [CN]: RN7713C) (Cinnaclon Company, Iran). Briefly, 200 µL of blood was mixed with 200 µL of RNX solution and after mixing; 50 µL of chloroform was added and incubated at 4ºC for 5 minutes. Then, the samples were centrifuged at 12 000 rpm for 8 minutes. The supernatant was transferred into a new RNase free tube and 500 µL of 90% ethanol was added and mixed gently. After centrifugation at similar conditions, the supernatant was discarded and 70% ethanol was added to the tubes. After centrifugation at similar conditions, the supernatant was discarded and the tubes were incubated at room temperature to dry out the samples. Finally, 30 µL of RNase free water was added to resolve the purified RNA. The purified RNA was reversely transcribed to the cDNA using the Easy cDNA Synthesis kit (CN: A101162) (Pasteur Institute of Iran). In brief, the purified RNA and oligo-dT primers were incubated at 70ºC and then cooled. The premix solution (containing reverse transcriptase enzyme, deoxynucleotides, and 95 suitable buffer) was added and incubated at 40ºC for 60 minutes. Data Analysis Calculation of data normality using the Kolmogorov-Smirnov test revealed that the data had a normal distribution. Thus, the differences between the patients with good and bad sexual functions were calculated using the parametric tests (t test). After the Levene test validation, P value < 0.05 was reported to be significant.
Results
The results revealed the mean expression of MDA5 mRNA levels in the female T2D patients with bad desire, arousal, lubrication, orgasm, satisfaction, pain and gen- tion (t: 480, df: 32, P = 0.634), satisfaction (t: 0.480, df: 32, P = 0.635), pain (t: -0.276, df: 32, P = 0.784) and generally (t: 0.323, df: 32, P = 0.749) sexual malfunctions in the female T2D patients ( Figure 2 ).
Discussion
This study aimed to examine the correlation between the MDA5 and RIG-1 expression levels and sexual malfunctions in the female T2D patients. The results showed the RIG-1 expression increased significantly in the patients with bad orgasm, compared to the patients with good orgasm. Based on the fact that RIG-1, as an intracellular receptor, participates in the induction of inflammation, hence, it may be concluded that female T2D patients may suffer from bad orgasm because of induction/stimulation of inflammation in a RIG-1 dependent manner. Additionally, RIG-1 activates interferon regulatory factors (IRFs) which transcribes from type 1 interferons (IFN-Is).
11
IFN-Is are important cytokines which interfere with brain functions in several disorders such as multiple sclerosis and Alzheimer. 11 It is also proposed that the elevated levels of RIG-1 in the female T2D patients with bad orgasm is related to the increased expression of IFN-Is and their (Figure 1 ). There were insignificant differences between bad and good desire (t: -261, df: 27.00, P = 0.796), arousal (P = 0.292, t: 1.076, df: 25.662), lubrication (t: 1.216, df: 27.00, P = 0.234), orgasm (t: 0.935, df: 27.00, P = 0.358), satisfaction (t: 1.174, df: 27.00, P = 0.251), pain (t: 0.954, df: 27.00, P = 0.348) and generally (t: 1.216, df: 27.00, P = 0.235) sexual malfunctions in the female T2D patients (Figure 1) . Expression of RIG-1 was increased significantly (t: 2.128, df: 29.532, P = 0.042) in the female T2D patients with bad orgasm (27.75 ± 10.11) compared to the patients with good orgasm (5.37 ± 2.87). Expression of RIG-1 was not associated with bad and good desire (t: 159, df: 32, P = 0.875), arousal (t: 419, df: 32, P = 0.678), lubrica-effects on the brain functions. There was no correlation between the expression of MDA5 and sexual functions of the female T2D patients, suggesting that MDA5 cannot be involved in the sexual malfunctions in the female T2D patients. Several studies have demonstrated the role of inflammation in the induction of bad orgasm in the females. 12 Additionally, mental disorders are the main causes of sexual malfunctions in the female T2D patients 13, 14 ; therefore, due to high prevalence of mental disorders in the patients, it has been hypothesized that the mental disorders are the main causes of sexual malfunctions in the female T2D patients. Interestingly, the authors have already reported that mental disorders can be associated with the altered expressions of the innate immunity related molecules and inflammation induction. 15, 16 . Thus, it may be hypothesized that increased expression of RIG-1 in the female T2D patients with the bad orgasm may be associated with mental disorders. This study evaluated the correlation between the MDA5 and RIG-1expression levels and sexual malfunctions. However, the limitation of this study was small sample size. Hence, more investigations are required to improve our knowledge regarding the role of intracellular receptors such as MDA5 and RIG-1, on the sexual function. It is also suggested that future investigations focus on the RIG-1 as a target for the treatment of sexual malfunctions in the female T2D patients.
Conclusion
This study showed that RIG-1 may participate in the induction of bad orgasm through the induction of inflammation in the female T2D patients. This study also suggested that RIG-1 may be involved in the induction of bad orgasm through other mechanisms.
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